In vitro susceptibility of human gut microbes to potential food preservatives based on immobilized phenolic compounds.


Journal

Food chemistry
ISSN: 1873-7072
Titre abrégé: Food Chem
Pays: England
ID NLM: 7702639

Informations de publication

Date de publication:
01 Jun 2022
Historique:
received: 29 11 2021
revised: 31 12 2021
accepted: 09 01 2022
pubmed: 19 1 2022
medline: 9 2 2022
entrez: 18 1 2022
Statut: ppublish

Résumé

The development of novel food preservatives based on natural antimicrobials such as phenolic compounds is increasing, but their safety should be established before use, including evaluating their impact on the gut microbiota. This work explored the influence of antimicrobial phenolics presented in different forms on selected human gut microbiota members through in vitro susceptibility tests. The bacteria tested exhibited a wide range of susceptibilities to phenolics depending on the molecule structure and mode of administration. Agathobacter rectalis and Clostridium spiroforme, members of the phylum Firmicutes, were the most sensitive strains. Susceptibility was strain- and species-specific, suggesting that it may not be possible to easily extrapolate results across the human microbiome in general. Species of other phyla including Bacteroidetes, Actinobacteria, Proteobacteria and Verrucomicrobia were more resistant than Firmicutes, with growth of some strains even enhanced. Our results provide insights into the biocompatibility of free and immobilized phenolics as potential food additives.

Identifiants

pubmed: 35042114
pii: S0308-8146(22)00097-8
doi: 10.1016/j.foodchem.2022.132136
pii:
doi:

Substances chimiques

Food Preservatives 0
RNA, Ribosomal, 16S 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

132136

Informations de copyright

Copyright © 2022 Elsevier Ltd. All rights reserved.

Auteurs

María Ruiz-Rico (M)

Departamento de Tecnología de Alimentos, Universitat Politècnica de València, Valencia, Spain. Electronic address: maruiri@etsia.upv.es.

Simone Renwick (S)

Department of Molecular and Cellular Biology, University of Guelph, Guelph, Ontario, Canada.

Emma Allen-Vercoe (E)

Department of Molecular and Cellular Biology, University of Guelph, Guelph, Ontario, Canada.

José M Barat (JM)

Departamento de Tecnología de Alimentos, Universitat Politècnica de València, Valencia, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH